Skip to content

Efficacy Investigation of Kuntai Capsule for the Add-back Therapy of GnRH-a Administration to Endometriosis Patients with Conservative Surgery

Efficacy Investigation of Heyan Kuntai Capsule for the Add-back Therapy of GnRH-a Administration to Endometriosis Patients with Conservative Surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900028624
Enrollment
Unknown
Registered
2019-12-29
Start date
2022-02-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometriosis

Interventions

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Laparoscopic diagnosis of endometriosis; 2. Perform conservative surgery to cut or destroy all visible ectopic endometrial lesions; 3. Consent to GnRH-a treatment after surgery; 4. Sign informed consent and volunteer to join the study.

Exclusion criteria

Exclusion criteria: 1. Suspected or confirmed malignant tumor patients; 2. Patients with adenomyosis or uterine fibroids; 3. Application of drugs that affect ovarian function such as oral contraceptives, GnRHa analogs, danazol, and Zishen Yutai Wan within the past 3 months; 4. Those who are allergic to the drugs in the trial; 5. Patients with serious diseases such as cardiovascular, cerebrovascular, liver, kidney or hematopoietic system or mental illness; 6. Suspected or have a history of alcohol or drug abuse, or other diseases or conditions that reduce or complicate enrollment according to the investigator's judgment, such as frequent changes in the work environment and unstable living environment. Loss of follow-up; 7. Other patients identified by the investigator as inappropriate for this study.

Design outcomes

Primary

MeasureTime frame
Kupperman score;VAS score;

Secondary

MeasureTime frame
FSH;E2;LH;AFC;CA125;

Countries

China

Contacts

Public ContactXie Meiqing

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

mqxie123@163.com+86 18922182801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026